Athira Pharma Inc (ATHA)

$2.74 0.18 (7.03%)
16:00 EDT ATHA Stock Quote Delayed 30 Minutes

Athira Pharma (ATHA) Stock Plunges 65% on Disappointing Drug Trial Results

Athira Pharma (ATHA) stock is plummeting on Wednesday following the outcome of a Phase 2 clinical trial of fosgonimeton.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Select Price, Percent change, or Dollar change as the y-axis.
Select Area, Line, OHLC or Candlestick as the chart type.
Previous Close -
Market Cap 104.27M
PE Ratio -1.81
EPS -1.51
Volume (Avg. Vol.) 578,095
Day's Range $2.55 - $2.83
52-Week Range $1.33 - $4.30
Dividend & Yield N/A (N/A)